Supreme Cannabis says it believes that Malta is “strategically located to serve export markets throughout Europe”. Should the company receive the license, it would allow the firm to produce and process cannabis for medical use within Malta, and to export cannabis for medical use to certain international markets.

The company intends to manufacture products containing EU GMP quality cannabis oil and pursue regulated medical cannabis distribution opportunities in the European Union.

“We’re pleased to announce that we have secured a letter of intent from Malta Enterprises, taking another step forward in our global growth strategy. Malta is not only a strategic hub for Europe, but it is also home to robust existing pharmaceutical and nutraceutical manufacturing industries with a deep pool of expertise,” said Navdeep Dhaliwal, CEO of The Supreme Cannabis Company.

“Using the intellectual property and expertise we’ve gained in Canada, we intend to deliver high-quality cannabis products to medical patients in multiple international markets,” the CEO added.

The Supreme Cannabis Company is a Canadian publicly traded company committed to providing premium brands and products. The Company’s portfolio includes its wholly-owned subsidiary and multi-award-winning brand, 7ACRES, which is a federally licensed producer of cannabis operating inside a 440,000-square-foot facility in Kincardine, Ontario.

The post Supreme Cannabis signs letter of intent with Malta Enterprises first appeared on The Malta Business Weekly.